Skip to content

    OXYGENTA PHARMACEUTICAL LIMITED

    Overview

    Price

    Market Cap

    ₹205 Cr

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY20FY21FY22FY23FY24FY25FY26FY26
    LiabilitiesEquity Capital1010141433373737
    Reserves-51-48-49-60-54-62-74-80
    Borrowings27485268576273110
    Other Liabilities3324143226468153
    Total Liabilities193431546383117120
    AssetsFixed Assets1116202829404148
    CWIP01000000
    Investments00000000
    Other Assets717112634447572
    Total Assets193431546383117120

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25FY26
    ActivitiesCash from Operating-8-3-2-2-2-133-28
    Cash from Investing-10-7-5-10-4-11-14
    Cash from Financing83961117943
    SummaryCapital Expenditure
    Free Cash Flow-8-3-8-7-11-17-9-41
    FCF Margin

    Valuation

    Cyclical, with too little history

    This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.

    OXYGENTAPH · CYCLICAL_UNMODELABLE

    Learn to analyse OXYGENTA PHARMACEUTICAL LIMITED

    Guides on how to read this kind of business and the numbers that matter.